Abstract:Anaphylactic reactions caused by injection of protamine sulfate during cardiac surgery are a well-known complication. A systematic literature review was therefore conducted to gather evidence of the knowledge concerning these side effects, and to see if any prospective randomized studies supported this. Studies investigating the effect of protamine sulfate in human beings were extracted from MEDLINE, Embase and the Cochrane Library, retrieving 487 articles. Abstracts were evaluated by both authors, and referre… Show more
“…Hypersensitivity reactions mediated by IgG, IgE, complement activation, and nonspecific histamine release have been reported [17,98]. Patients who have been previously exposed to this drug are at higher risk of developing a reaction, whether the drug was given for blocking heparin effect or combined with insulin.…”
Section: B) High Molecular Weight Agentsmentioning
Perioperative hypersensitivity reactions constitute a first-line problem for anesthesiologists and allergists, so it is advisable that hospitals have a consensus protocol for the diagnosis and management of these reactions. However, this kind of protocols is not present in many hospitals, leading to problems in treatment, the communication of incidents and subsequent etiological diagnosis. In this document we present a systematic review of the available scientific evidence and provide general guidelines for the management of acute episodes and
Resumen:Las reacciones de hipersensibilidad perioperatorias constituyen un problema de primera línea para los anestesiólogos y alergólogos, por lo que es recomendable que los hospitales tengan un protocolo de consenso para el diagnóstico y el tratamiento de estas reacciones. Sin embargo, este tipo de protocolos no está presente en muchos hospitales, lo que conlleva problemas en el tratamiento, la comunicación de incidentes y el posterior diagnóstico etiológico. Este documento ha sido creado por miembros del Comité de Alergia a Medicamentos de la Sociedad Española de Alergia e Inmunología Clínica (SEAIC) en colaboración con miembros de la Sociedad Española de Anestesia (SEDAR). Se ha realizado una revisión sistemática de la evidencia científica disponible y se proporcionan pautas generales para el manejo de episodios agudos y para la derivación de pacientes con reacciones de hipersensibilidad perioperatoria a los Servicios de Alergología. Se propone un algoritmo práctico para el diagnóstico etiológico y se brindan recomendaciones para el manejo de pacientes con reacciones alérgicas perioperatorias.
“…Hypersensitivity reactions mediated by IgG, IgE, complement activation, and nonspecific histamine release have been reported [17,98]. Patients who have been previously exposed to this drug are at higher risk of developing a reaction, whether the drug was given for blocking heparin effect or combined with insulin.…”
Section: B) High Molecular Weight Agentsmentioning
Perioperative hypersensitivity reactions constitute a first-line problem for anesthesiologists and allergists, so it is advisable that hospitals have a consensus protocol for the diagnosis and management of these reactions. However, this kind of protocols is not present in many hospitals, leading to problems in treatment, the communication of incidents and subsequent etiological diagnosis. In this document we present a systematic review of the available scientific evidence and provide general guidelines for the management of acute episodes and
Resumen:Las reacciones de hipersensibilidad perioperatorias constituyen un problema de primera línea para los anestesiólogos y alergólogos, por lo que es recomendable que los hospitales tengan un protocolo de consenso para el diagnóstico y el tratamiento de estas reacciones. Sin embargo, este tipo de protocolos no está presente en muchos hospitales, lo que conlleva problemas en el tratamiento, la comunicación de incidentes y el posterior diagnóstico etiológico. Este documento ha sido creado por miembros del Comité de Alergia a Medicamentos de la Sociedad Española de Alergia e Inmunología Clínica (SEAIC) en colaboración con miembros de la Sociedad Española de Anestesia (SEDAR). Se ha realizado una revisión sistemática de la evidencia científica disponible y se proporcionan pautas generales para el manejo de episodios agudos y para la derivación de pacientes con reacciones de hipersensibilidad perioperatoria a los Servicios de Alergología. Se propone un algoritmo práctico para el diagnóstico etiológico y se brindan recomendaciones para el manejo de pacientes con reacciones alérgicas perioperatorias.
“…However, excess protamine may be harmful to the patient as it can have its own anticoagulant and hemodynamic effects. [16][17][18][19] Thus, it is important to diagnose the presence of circulating heparin in the postoperative cardiac surgical patient. We hypothesized that persistence of residual circulating heparin may be reflected by elevation of APTT, a test that is routinely available.…”
“…Il est clair pour tous que la protamine n'est pas un médicament inoffensif, et ses effets secondaires sont discutés en profondeur ailleurs. 2,3 Le fait que la protamine soit elle-même une antithrombine et un inhibiteur plaquettaire est peu reconnu. En administrant davantage de protamine en réponse à un aPTT élevé, une équipe médi-cale pourrait inconsciemment augmenter plutôt que réduire les saignements du patient.…”
unclassified
“…Clearly, protamine is not an innocuous drug, as its side effects are extensively discussed elsewhere. 2,3 The fact that protamine is itself an anti-thrombin agent and a platelet inhibitor is little appreciated. By administering more protamine in response to an elevated aPTT, a physician team could unwittingly increase, rather than abate, bleeding.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.